Dr. Michael D. Kluger, MD, MPH

Dr. Kluger practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Kluger's NPI, 1891866976, was assigned on November 12, 2006. Dr. Kluger graduated from New York University School of Medicine in 2004. Dr. Kluger's New York license number on file is 238450.

Dr. Kluger's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Kluger's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Kluger is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Kluger to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kluger practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kluger's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Kluger is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Kluger's licenses on file in 3 states: New York, Connecticut and New Jersey.

Dmand AI lists esophagus, stomach, or upper small intestine surgery, gallbladder removal and gastrointestinal obstruction among the conditions Dr. Kluger treats.

CMS data shows 208 Medicare services from Dr. Kluger across 7 procedure codes in 2024, for 180 Medicare patients. Medicare paid $23,986 for them.

CMS counts 180 Medicare patients who saw Dr. Kluger in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kluger's median patient age at 69, with 42% women.

In 2024, Dr. Kluger wrote 48 Medicare Part D claims for 29 patients. 96% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kluger for performance year 2024, reported through an alternative payment model (APM). Dr. Kluger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kluger as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 111 papers to Dr. Kluger, published from 2010 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Pancreatic Neoplasms, Hepatectomy and Pancreatectomy. Dr. Kluger has published most often in HPB (Oxford). Dr. Kluger's most frequent co-authors are John A. Chabot, MD, Beth Anne Schrope, MD and Kazuki Md Sugahara, MD, PhD.

Dmand AI links Dr. Kluger to 4 clinical trials. 4 are still active or recruiting. Conditions studied include Carcinoma, Pancreatic Ductal, Carcinoma, Ductal and Adrenocortical Carcinoma. Angiodynamics, Inc. sponsors the most, 2.

CMS Open Payments shows 31 general payments to Dr. Kluger from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Ethicon Inc. paid the most, $528.

Dmand AI lists 15 awards for Dr. Kluger, most recently Top Doctors in 2025.

Dr. Kluger graduated from New York University School of Medicine in 2004. Dr. Kluger is a member of AOA, ACS, Americas Hepato-Pancreato-Biliary Association, AAS, SSAT and SSO.

Dr. Kluger is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.